
Psychedelic Psychopharmacology | Spring 2023
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Faculty
Dates & Times
Course skips 05/29, 06/19, & 07/03
Location
Cost
Course Description
This reading and study group will maintain the same membership for the 12-week period. The group will have a syllabus with readings that participants will be expected to read prior to each discussion group meeting. The format for each session will include a short review of each paper by the group leader, followed by a discussion of the content and group members’ perspectives of the topic. This is an active group and weekly participation is required. The group is ideal for clinicians, graduate students, researchers, or the public, so long as they have training or interest in the biological responses that may influence the efficacy and safety of psychedelic therapy. Readings will include publications in the academic literature. The articles will provide an overview of psychedelic effects investigated by a variety of scientific methods (pharmacodynamics, pharmacokinetics, pharmacogenomics, neuroscience) for several types of psychedelics (e.g., psilocybin, ayahuasca, MDMA, ketamine). Teachings are appropriate for healthcare professionals as well as the general public. Healthcare professionals will be able to incorporate the tools and practices offered in this program in ways beneficial to clients or patients.
A limited number of Diversity Fund scholarships are available, please complete this application, in addition to the course application.
Learning Objectives
At the end of this course, the participant will be able to:
- Describe pharmacokinetic properties of psilocybin to predict potential drug interactions and adverse effects
- Describe pharmacokinetic properties of ayahuasca to predict potential drug interactions and adverse effects
- Describe pharmacokinetic properties of MDMA to predict potential drug interactions and adverse effects
- Describe pharmacokinetic properties of ketamine to predict potential drug interactions and adverse effects
- Explain how the pharmacodynamics of psilocybin affects clinical and serological biomarkers
- Explain how the pharmacodynamics of ayahuasca affects clinical and serological biomarkers
- Explain how the pharmacodynamics of MDMA affects clinical and serological biomarkers
- Explain how the pharmacodynamics of ketamine affects clinical and serological biomarkers
- Discuss the effects of psilocybin on neural network function
- Discuss the effects of ayahuasca on neural network function
- Discuss the effects of MDMA on neural network function
- Discuss the effects of ketamine on neural network function
Perks
- Registration includes access to our online classroom, course handouts, and private course discussion board. All attendees may opt to be added to our professional community email list of about 1,000 professionals who have completed this (or similar) courses with us.
Other Upcoming Courses

FULL – Psychedelic Integration: Premise & Promise Hybrid | February 2023

Psychotherapeutic Touch Workshop | Winter 2023

Buddhism & Psychedelic Therapy | Winter 2023

Psychoanalytic Psychedelic Clinical Consultation Group | Spring 2023

Psychedelic Integration: Premise & Promise Hybrid | March 2023

Foundations of Psychedelic Therapy | Spring 2023

Integration Essentials, Evenings | Spring 2023

Psychedelic Integration: Premise & Promise Hybrid | April 2023

Psychedelic Integration: Premise & Promise Hybrid | May 2023

Integration Essentials | Spring 2023

Poetry, Symbols, and Story in Psychedelic Therapy | Spring 2023

Psychedelic Integration: Experiential Practice Retreat | Spring, 2023

Psychedelic Integration: Experiential Practice Retreat | Fall 2023

Psychotherapeutic Touch Workshop | Winter 2023

Buddhism & Psychedelic Therapy | Winter 2023

KAP Theory & Methodology | Spring 2023

Foundations of Psychedelic Therapy | Spring 2023

KAP for Couples & Groups: Clinical Consultation Group | Spring 2023

Integration Essentials, Evenings | Spring 2023

Integration Essentials | Spring 2023

Understanding Ketamine | May 2023

Poetry, Symbols, and Story in Psychedelic Therapy | Spring 2023

Psychedelic Integration: Experiential Practice Retreat | Spring, 2023

KAP Theory & Methodology | Summer 2023

Psychedelic Integration: Experiential Practice Retreat | Fall 2023

FULL – Psychedelic Integration: Premise & Promise Hybrid | February 2023

Psychotherapeutic Touch Workshop | Winter 2023

Buddhism & Psychedelic Therapy | Winter 2023

Putting Psychedelic Integration into Practice | Webinar

Psychoanalytic Psychedelic Clinical Consultation Group | Spring 2023

Psychedelic Integration: Premise & Promise Hybrid | March 2023

Understanding Ketamine | March 2023

Psilocybin-Assisted Therapy: Part 1 | Cohort 23B

KAP Theory & Methodology | Spring 2023

Foundations of Psychedelic Therapy | Spring 2023

KAP for Couples & Groups: Clinical Consultation Group | Spring 2023

Integration Essentials, Evenings | Spring 2023

Psychedelic Integration: Premise & Promise Hybrid | April 2023

Psilocybin-Assisted Therapy: Part 1 | Cohort 23C

Psychedelic Integration: Premise & Promise Hybrid | May 2023

Integration Essentials | Spring 2023

Understanding Ketamine | May 2023

Trauma-Informed Psychedelic-Assisted Therapy | Spring 2023

Poetry, Symbols, and Story in Psychedelic Therapy | Spring 2023

Psychedelic Integration: Experiential Practice Retreat | Spring, 2023

KAP Theory & Methodology | Summer 2023
